Management of Recurrent UTI in Older Males

Initial Diagnostic Approach

The European Urology guidelines recommend obtaining urine culture with antimicrobial susceptibility testing before initiating any treatment in males with recurrent UTIs, as they have a broader microbial spectrum and higher likelihood of antimicrobial resistance 1, 2
Older patients with UTIs frequently present with atypical symptoms, such as confusion, functional decline, fatigue, and falls, rather than classic dysuria and frequency 3, 4
Males have a broader microbial spectrum than uncomplicated UTIs, including E. coli, Proteus spp., Klebsiella spp., Pseudomonas spp., Serratia spp., and Enterococcus spp. 1
Antimicrobial resistance is more likely in complicated UTIs 1

The European Urology guidelines recommend empirical therapy with oral options such as ciprofloxacin 500-750 mg twice daily for 7-14 days, levofloxacin 750 mg once daily for 7-14 days, or trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days, based on illness severity and local resistance patterns 1, 5
Parenteral options such as ciprofloxacin 400 mg IV twice daily, levofloxacin 750 mg IV once daily, or ceftriaxone 1-2 g IV once daily may be used in systemically unwell patients or those unable to take oral medications 1
Therapy should be tailored once culture results return and continued for 14 days total when prostatitis cannot be excluded 1

Methenamine hippurate 1 g twice daily is a non-antibiotic prophylaxis option with strong evidence, working by releasing formaldehyde in acidic urine and being non-inferior to antibiotic prophylaxis 6, 5
Additional behavioral modifications, such as increasing fluid intake, avoiding prolonged holding of urine, and maintaining adequate hydration, may help prevent recurrence 5
Immunoactive prophylaxis is strongly recommended for reducing recurrent UTIs in all age groups 6, 5
D-mannose 2 g daily may be considered but has weaker evidence than methenamine hippurate 6
Continuous low-dose antibiotic prophylaxis, such as trimethoprim-sulfamethoxazole or nitrofurantoin, may be reserved for when non-antimicrobial interventions have failed 6, 5

Account for polypharmacy and comorbidities when selecting antibiotics, checking for drug interactions, adjusting doses for renal function, and monitoring for adverse effects more closely 3, 4
Do not treat asymptomatic bacteriuria, as this increases antimicrobial resistance without improving outcomes 5
If symptoms persist after 72 hours of appropriate therapy or the patient remains febrile, consider imaging to evaluate for prostatic abscess, renal abscess, or obstruction requiring intervention 2, 5

Imaging of the upper urinary tract and assessment for bladder outlet obstruction is recommended to identify correctable abnormalities, particularly in males with recurrent UTIs 1

Instruct the patient to return immediately if symptoms do not resolve within 4 weeks after treatment completion, symptoms recur within 2 weeks, or signs of pyelonephritis develop 2
Perform repeat urine culture if symptoms persist at the end of treatment or recur within 2 weeks, but do not perform routine post-treatment cultures in asymptomatic patients 2